Main menu

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a not-for-profit organization, dedicated to a close interaction between clinical scientists dealing with bone, joint and muscle disorder, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of Osteoporosis and Osteoarthritis within the comprehensive perspective of health resources utilization.

The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

ATLAS OF OSTEOARTHRITIS

Recently published by Springer Healthcare in partnership with the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the Atlas of Osteoarthritis - Second Edition is now FREE to download for the ESCEO Associate Members.

It includes an updated chapter on the treatment of osteoarthritis and a new chapter on SYSADOAs.

Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.

Discover the official journal of ESCEO on Springer.com and read the journal contents on Springerlink.com.You can get the table of contents of every new issue published in Aging Clinical and Experimental Research. Sign up for the ToC Alert for this journal with your e-mail address. It’s easy and it’s free.

WCO-IOF-ESCEO Krakow 2018

WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASESWe would like, on behalf of the Organizing Committee of the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO Krakow 2018), to thank you very much for your tremendous participation to the Congress.We are very proud to inform you that the 18th edition of the WCO-IOF-ESCEO Congress was a huge success!

3965 delegates took part in the largest event in the field of osteoporosis, osteoarthritis, frailty and sarcopenia.The Scientific Advisory Committee, co-chaired by Professor René Rizzoli and Professor Cyrus Cooper, had an extremely difficult task, to select oral presentations, among 1513 submitted abstracts of the highest quality.565 Awards were distributed during the congress.We thank you once again for your much appreciated and active participation during the Congress.

The future edition of the WCO-IOF-ESCEO Congress will be held in 2019 in Paris (France). We are eagerly looking forward to counting you among our privileged participants for this future edition.

Kindest personal regards,

Jean-Yves Reginster,President ESCEO

John A. Kanis,President IOF

ABSTACT BOOK

1.513 abstracts were submitted for this 2018 edition of the WCO-IOF-ESCEO! This extraordinary number of abstracts is the largest ever recorded since the beginning of the Congress.

We invite you to discover the abstracts selected for the WCO-IOF-ESCEO by accessing the Abstract Book under this link.

"Why Patented Crystalline Glucosamine Sulfate (pCGS) is different from Other Glucosamines in the Treatment of Osteoarthritis (OA) and Should be Recommended as First Line Therapy"

In December 2015, the paper published by Olivier Bruyère, member of the Scientific Advisory Board of ESCEO, in Seminars in Arthritis and Rheumatism (2014) has benefited from a high visibility in the Asian press: a total of 160 media postings in Thailand, China, Russia and in international outlets with a potential audience of almost 80.000.000 visitors a day.

This is a huge opportunity for ESCEO and for our Osteoarthritis Treatment Algorithm to be seen and read all over the world.